Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
ARMP Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
ARMP Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
ARMP deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 859,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 20,000 | |
| 58,000 | |
| 86,000 | |
| 933,000 | |
| 18,000 | |
| 43,000 | |
| 142,000 | |
| 245,000 | |
| 247,000 | |
| 350,000 | |
| 142,000 | |
| 244,000 | |
| 246,000,000 | |
| 349,000,000 | |
| 140,000,000 | |
| 0 | |
| 482,000 | |
| 302,000 | |
| 1,776,000 | |
| 1,227,000 | |
| 1,865,000 | |
| 1,673,000 | |
| 84,000 | |
| 79,000 | |
| 218,000 | |
| 67,000 | |
| 93,000 | |
| 251,000 | |
| 323,000 | |
| 143,000 | |
| 750,000 | |
| 278,000 | |
| 0 | |
| 143,000 | |
| 0 | |
| 0 | |
| 504,000 | |
| 2,767,000 | |
| 2,784,000 | |
| 1,180,000 | |
| 2,365,000 | |
| 5,237,000 | |
| 5,324,000 | |
| 6,041,000 | |
| 6,925,000 | |
| 6,072,000 | |
| 4,473,000 | |
| 4,631,000 | |
| 5,117,341 | |
| 6,752,363 | |
| 7,578,281 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |